Ignite Creation Date:
2024-05-06 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04737239
Status:
RECRUITING
Last Update Posted:
2023-11-07
First Post:
2021-01-21
Brief Title:
Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG Studies
Sponsor:
Henry Ford Health System
Organization:
Henry Ford Health System
Study Overview
Official Title:
Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Carpal Tunnel Syndrome CTS is the most common nerve entrapment syndrome worldwide There are currently no studies examining the effectiveness of corticosteroid injections in patients with normal negative EMG studies The purpose of this study is to gain a better understanding of the duration of symptom improvement post corticosteroid injection in patients with negative or mild EMG studies The Boston Carpal Tunnel Questionnaire will be given to patients undergoing corticosteroid injections for the treatment of carpal tunnel syndrome to assess their response to the injection Investigators will collect data retrospectively The Boston Carpal Tunnel Questionnaire BCTQ is administered as per standard protocol to all patients with CTS who have a negative or mild EMG study The BCTQ assesses the patients self-reported symptom severity and functional status Investigators will analyze this data with respect to demographics as well as numbness in the median n distribution nocturnal numbness weaknessatrophy of the thenar musculature Tinels sign Phalens test loss of 2-point discrimination Quick-Dash score and grip strength score
The primary outcome will be the Boston Carpal Tunnel Questionnaire outcome score under the different EMG conditionsThe secondary outcomes will be numbness in the median n distribution nocturnal numbness weaknessatrophy of the thenar musculature Tinels sign Phalens test loss of 2-point discrimination QuickDash score and grip strength score Both outcomes will be examined in patients with negative or mild EMG readings This information will allow orthopedic physicians to gain a better understanding of the duration of symptom improvement post-corticosteroid injection allowing them to fine tune their treatment plans for CTS patients
The primary outcome will be the Boston Carpal Tunnel Questionnaire outcome score under the different EMG conditionsThe secondary outcomes will be numbness in the median n distribution nocturnal numbness weaknessatrophy of the thenar musculature Tinels sign Phalens test loss of 2-point discrimination QuickDash score and grip strength score Both outcomes will be examined in patients with negative or mild EMG readings This information will allow orthopedic physicians to gain a better understanding of the duration of symptom improvement post-corticosteroid injection allowing them to fine tune their treatment plans for CTS patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None